Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
539,069
-
Share change
-
+13,666
-
Total reported value
-
$25,093,000
-
Price per share
-
$46.53
-
Number of holders
-
16
-
Value change
-
+$642,217
-
Number of buys
-
5
-
Number of sells
-
9
Institutional Holders of NOVOZYMES AS/FI - ADR (NVZMY) as of Q2 2019
As of 30 Jun 2019,
NOVOZYMES AS/FI - ADR (NVZMY) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
539,069 shares.
The largest 10 holders included
Parametric Portfolio Associates LLC, BOSTON FINANCIAL MANGEMENT LLC, Lenox Wealth Management, Inc., ZEVIN ASSET MANAGEMENT LLC, Boston Common Asset Management, LLC, Moloney Securities Asset Management, LLC, Hemenway Trust Co LLC, Douglass Winthrop Advisors, LLC, PNC Financial Services Group, Inc., and QUADRANT CAPITAL GROUP LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.